logo-loader
viewArcher Materials Ltd

Full interview: Archer Materials advances first-phase prototype of graphene biosensor technology

Archer Materials Ltd (ASX:AXE) chief executive officer Dr Mohammad Choucair updates Proactive on advancing the first-phase prototype of disease-detecting graphene ink biosensors with the company’s graphene biosensor technology.

The CEO takes us through how the technology to print human antibodies on these graphene biosensors can assist human health outcomes.

Quick facts: Archer Materials Ltd

Price: 0.215 AUD

ASX:AXE
Market: ASX
Market Cap: $45.67 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Archer Materials Ltd named herein, including the promotion by the Company of Archer Materials Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Immotion plans fundraising following deal with Las Vegas resort

Immotion Group (LON:IMMO) has raised gross proceeds of £2.85mln from an 'oversubscribed' fundraising to accelerate its growth plans, and revealed it has inked a revenue-sharing deal with the MGM Mandalay Bay resort and casino in Las Vegas. CEO Martin Higginson tells Proactive London what the...

11 minutes ago

2 min read